153 related articles for article (PubMed ID: 22333459)
21. Methylation status of HPV16 E2-binding sites classifies subtypes of HPV-associated oropharyngeal cancers.
Reuschenbach M; Huebbers CU; Prigge ES; Bermejo JL; Kalteis MS; Preuss SF; Seuthe IM; Kolligs J; Speel EJ; Olthof N; Kremer B; Wagner S; Klussmann JP; Vinokurova S; von Knebel Doeberitz M
Cancer; 2015 Jun; 121(12):1966-76. PubMed ID: 25731880
[TBL] [Abstract][Full Text] [Related]
22. SMCX and components of the TIP60 complex contribute to E2 regulation of the HPV E6/E7 promoter.
Smith JA; Haberstroh FS; White EA; Livingston DM; DeCaprio JA; Howley PM
Virology; 2014 Nov; 468-470():311-321. PubMed ID: 25222147
[TBL] [Abstract][Full Text] [Related]
23. NRIP enhances HPV gene expression via interaction with either GR or E2.
Chang SW; Lu PY; Guo JH; Tsai TC; Tsao YP; Chen SL
Virology; 2012 Feb; 423(1):38-48. PubMed ID: 22177699
[TBL] [Abstract][Full Text] [Related]
24. Promoter activity of sequences located upstream of the human papillomavirus types of 16 and 18 late regions.
Geisen C; Kahn T
J Gen Virol; 1996 Sep; 77 ( Pt 9)():2193-200. PubMed ID: 8811019
[TBL] [Abstract][Full Text] [Related]
25. Nuclear matrix attachment regions of human papillomavirus type 16 point toward conservation of these genomic elements in all genital papillomaviruses.
Tan SH; Bartsch D; Schwarz E; Bernard HU
J Virol; 1998 May; 72(5):3610-22. PubMed ID: 9557642
[TBL] [Abstract][Full Text] [Related]
26. Mutations in the human papillomavirus type 16 E2 protein identify multiple regions of the protein involved in binding to E1.
Piccini A; Storey A; Massimi P; Banks L
J Gen Virol; 1995 Nov; 76 ( Pt 11)():2909-13. PubMed ID: 7595403
[TBL] [Abstract][Full Text] [Related]
27. Cell-type-specific separate regulation of the E6 and E7 promoters of human papillomavirus type 6a by the viral transcription factor E2.
Rapp B; Pawellek A; Kraetzer F; Schaefer M; May C; Purdie K; Grassmann K; Iftner T
J Virol; 1997 Sep; 71(9):6956-66. PubMed ID: 9261424
[TBL] [Abstract][Full Text] [Related]
28. Addition of a single E2 binding site to the human papillomavirus (HPV) type 16 long control region enhances killing of HPV positive cells via HPV E2 protein-regulated herpes simplex virus type 1 thymidine kinase-mediated suicide gene therapy.
Sharma R; Palefsky JM
Hum Gene Ther; 2010 Jul; 21(7):843-54. PubMed ID: 20132050
[TBL] [Abstract][Full Text] [Related]
29. Mutational analysis of cis elements involved in E2 modulation of human papillomavirus type 16 P97 and type 18 P105 promoters.
Romanczuk H; Thierry F; Howley PM
J Virol; 1990 Jun; 64(6):2849-59. PubMed ID: 2159546
[TBL] [Abstract][Full Text] [Related]
30. [Mutations in various functional domains of HPV2 E2 protein inhibit the transcriptional depression activities].
Gao C; Lei YJ; Jiang HY; Shi Q; Tian C; Han J; Dong XP
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2011 Jun; 25(3):164-6. PubMed ID: 21977580
[TBL] [Abstract][Full Text] [Related]
31. Bromodomain protein 4 mediates the papillomavirus E2 transcriptional activation function.
Schweiger MR; You J; Howley PM
J Virol; 2006 May; 80(9):4276-85. PubMed ID: 16611886
[TBL] [Abstract][Full Text] [Related]
32. P53 represses human papillomavirus type 16 DNA replication via the viral E2 protein.
Brown C; Kowalczyk AM; Taylor ER; Morgan IM; Gaston K
Virol J; 2008 Jan; 5():5. PubMed ID: 18190682
[TBL] [Abstract][Full Text] [Related]
33. Adeno-associated virus major Rep78 protein disrupts binding of TATA-binding protein to the p97 promoter of human papillomavirus type 16.
Su PF; Chiang SY; Wu CW; Wu FY
J Virol; 2000 Mar; 74(5):2459-65. PubMed ID: 10666281
[TBL] [Abstract][Full Text] [Related]
34. DNA structure and flexibility in the sequence-specific binding of papillomavirus E2 proteins.
Hines CS; Meghoo C; Shetty S; Biburger M; Brenowitz M; Hegde RS
J Mol Biol; 1998 Mar; 276(4):809-18. PubMed ID: 9500925
[TBL] [Abstract][Full Text] [Related]
35. DNA replicative functions of highly-expressed, codon-optimized human papillomavirus proteins E1 and E2.
Wang XM; Jansen KU; McClements WL
J Virol Methods; 2003 Mar; 108(1):83-90. PubMed ID: 12565157
[TBL] [Abstract][Full Text] [Related]
36. Crystal structure of the E2 DNA-binding domain from human papillomavirus type 16: implications for its DNA binding-site selection mechanism.
Hegde RS; Androphy EJ
J Mol Biol; 1998 Dec; 284(5):1479-89. PubMed ID: 9878365
[TBL] [Abstract][Full Text] [Related]
37. Human papillomavirus type 16 E2 protein transcriptionally activates the promoter of a key cellular splicing factor, SF2/ASF.
Mole S; Milligan SG; Graham SV
J Virol; 2009 Jan; 83(1):357-67. PubMed ID: 18945764
[TBL] [Abstract][Full Text] [Related]
38. Different arrangement of human papillomavirus E2 binding sites distinguishes cutaneous types from those associated with mucosal lesions.
Garrido-Guerrero E; Carrillo E; Guido M; Zamorano R; García-Carranca A; Gariglio P
Arch Med Res; 1996; 27(3):389-94. PubMed ID: 8854400
[TBL] [Abstract][Full Text] [Related]
39. Cellular transcription factors regulate human papillomavirus type 16 gene expression by binding to a subset of the DNA sequences recognized by the viral E2 protein.
Lewis H; Webster K; Sanchez-Perez AM; Gaston K
J Gen Virol; 1999 Aug; 80 ( Pt 8)():2087-2096. PubMed ID: 10466807
[TBL] [Abstract][Full Text] [Related]
40. CpG methylation of HPV 16 LCR at E2 binding site proximal to P97 is associated with cervical cancer in presence of intact E2.
Bhattacharjee B; Sengupta S
Virology; 2006 Oct; 354(2):280-5. PubMed ID: 16905170
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
